ANVS earnings: a negative outcome, -23.3%

On March 31, 2023, Annovis Bio, Inc. reached its earnings. The result was a negative outcome, and the stock moved -23.3% in the window around the event. It had already run +15.4% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.